As at Jul 25, 2024, the ALKS stock has a PE ratio of 16.21. This is based on the current EPS of $1.73 and the stock price of $28.04 per share. An increase of 10% has been recorded in the P/E ratio compared to the average of 14.7 of the last 4 quarters.
The mean historical PE ratio of Alkermes over the last two years is 22.05. The current 16.21 PE ratio is 26% below the historical average. In the past two years, ALKS's PE ratio was at its highest in the Jun 2023 quarter at 51.31, with a price of $31.3 and an EPS of $0.61. The Mar 2024 quarter recorded the bottom point at 10.33, with a price of $27.07 and an EPS of $2.62.
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 12.96 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
ALKS's current P/E ratio is lower than the 3, 5 and 10-year averages.
ALKS's PE ratio is lower than its peer stock AZN, but it is greater than JNJ's and NVS's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| NVS Novartis AG | 13.96 | $225.1B |
| ALKS Alkermes plc | 16.12 | $4.59B |
| AZN Astrazeneca plc | 37.56 | $242.2B |
| BMY Bristol Myers Squibb Co | N/A | $102.27B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.37B |
| PFE Pfizer Inc | N/A | $174.36B |
The price to earnings ratio for ALKS stock as of Jul 25, 2024, stands at 16.21.
As an average over the last 3 years, ALKS stock has a PE ratio of 22.05.
As an average over the last 5 years, ALKS stock has a PE ratio of 22.05.
The highest quarterly PE ratio in the last two years has been 51.31 and it was in the Jun 2023 quarter.
ALKS's current price to earnings ratio is 26% below its 2-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jul 25, 2024), Alkermes's stock price is $28.04. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $1.73. Therefore, Alkermes's P/E ratio for today is 16.21. PE RATIO(16.21) = STOCK PRICE($28.04) / TTM EPS($1.73)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.